FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204245666> ?p ?o ?g. }

• W3204245666 endingPage "1405" @default.
• W3204245666 startingPage "1395" @default.
• W3204245666 abstract "Aim: We investigated the efficacy and safety of hepatic artery infusion chemotherapy (HAIC) combined with anti-PD-1 immunotherapy and tyrosine kinase inhibitors (TKIs) for advanced hepatocellular carcinoma (HCC). Method: This retrospective study included HCC patients treated with HAIC, TKIs and anti-PD-1 antibodies between May 2019 and November 2020 in our hospital. Primary end points were progression-free survival and safety. Results: Twenty-seven advanced HCC patients were analyzed. The median follow-up was 12.9 months (range: 4.0-24.0 months) and the median progression-free survival was 10.6 months. The objective response rate and disease control rate were 63.0 and 92.6%, respectively. No treatment-related deaths occurred. Conclusion: In patients with advanced HCC, treatment with HAIC, anti-PD-1 antibodies and oral TKIs was effective and safe.Lay abstract Some tyrosine kinase inhibitors (TKIs) that inhibit tumor vessel growth, such as sorafenib and lenvatinib, have been recommended as first-line treatment for advanced hepatocellular carcinoma (HCC). In hepatic artery infusion chemotherapy, chemotherapeutic drugs can be delivered via a microcatheter to the tumor-supplying artery to increase the local drug concentration, leading to higher local disease control rates and less toxicity than systemic chemotherapy. The combination of anti-PD-1 immunotherapy plus TKIs was shown in a previous study to be a safe and effective treatment for advanced HCC. This study explored the safety and effectiveness of hepatic artery infusion chemotherapy, TKIs and an anti-PD-1 antibody for the treatment of advanced HCC and found that combination therapy is effective, with good tolerability." @default.
• W3204245666 created "2021-10-11" @default.
• W3204245666 creator A5003263031 @default.
• W3204245666 creator A5005375688 @default.
• W3204245666 creator A5006651636 @default.
• W3204245666 creator A5007542519 @default.
• W3204245666 creator A5007562507 @default.
• W3204245666 creator A5008319298 @default.
• W3204245666 creator A5010407734 @default.
• W3204245666 creator A5011090841 @default.
• W3204245666 creator A5018814025 @default.
• W3204245666 creator A5027824032 @default.
• W3204245666 creator A5031811618 @default.
• W3204245666 creator A5040205022 @default.
• W3204245666 creator A5052488776 @default.
• W3204245666 creator A5064754125 @default.
• W3204245666 date "2021-12-01" @default.
• W3204245666 modified "2023-10-17" @default.
• W3204245666 title "Real-world study of hepatic artery infusion chemotherapy combined with anti-PD-1 immunotherapy and tyrosine kinase inhibitors for advanced hepatocellular carcinoma" @default.
• W3204245666 cites W1971837077 @default.
• W3204245666 cites W1986865218 @default.
• W3204245666 cites W1994193851 @default.
• W3204245666 cites W2016170717 @default.
• W3204245666 cites W2079586464 @default.
• W3204245666 cites W2163346117 @default.
• W3204245666 cites W2331830492 @default.
• W3204245666 cites W2336895124 @default.
• W3204245666 cites W2460315959 @default.
• W3204245666 cites W2510113807 @default.
• W3204245666 cites W2511951051 @default.
• W3204245666 cites W2512061943 @default.
• W3204245666 cites W2560499218 @default.
• W3204245666 cites W2583804433 @default.
• W3204245666 cites W2606367731 @default.
• W3204245666 cites W2736166064 @default.
• W3204245666 cites W2787358630 @default.
• W3204245666 cites W2789635905 @default.
• W3204245666 cites W2805592007 @default.
• W3204245666 cites W2808529790 @default.
• W3204245666 cites W2839856130 @default.
• W3204245666 cites W2889646458 @default.
• W3204245666 cites W2890844400 @default.
• W3204245666 cites W2895572113 @default.
• W3204245666 cites W2897612290 @default.
• W3204245666 cites W2928593156 @default.
• W3204245666 cites W2944033593 @default.
• W3204245666 cites W2946053006 @default.
• W3204245666 cites W2947105080 @default.
• W3204245666 cites W2969381967 @default.
• W3204245666 cites W2977722669 @default.
• W3204245666 cites W2979523220 @default.
• W3204245666 cites W2990602950 @default.
• W3204245666 cites W3008514541 @default.
• W3204245666 cites W3022175752 @default.
• W3204245666 cites W3033005822 @default.
• W3204245666 cites W3035757716 @default.
• W3204245666 cites W3042091422 @default.
• W3204245666 cites W3045387409 @default.
• W3204245666 cites W3137429784 @default.
• W3204245666 cites W3167322268 @default.
• W3204245666 cites W3195864634 @default.
• W3204245666 cites W4231821582 @default.
• W3204245666 doi "https://doi.org/10.2217/imt-2021-0192" @default.
• W3204245666 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34607482" @default.
• W3204245666 hasPublicationYear "2021" @default.
• W3204245666 type Work @default.
• W3204245666 sameAs 3204245666 @default.
• W3204245666 citedByCount "22" @default.
• W3204245666 countsByYear W32042456662022 @default.
• W3204245666 countsByYear W32042456662023 @default.
• W3204245666 crossrefType "journal-article" @default.
• W3204245666 hasAuthorship W3204245666A5003263031 @default.
• W3204245666 hasAuthorship W3204245666A5005375688 @default.
• W3204245666 hasAuthorship W3204245666A5006651636 @default.
• W3204245666 hasAuthorship W3204245666A5007542519 @default.
• W3204245666 hasAuthorship W3204245666A5007562507 @default.
• W3204245666 hasAuthorship W3204245666A5008319298 @default.
• W3204245666 hasAuthorship W3204245666A5010407734 @default.
• W3204245666 hasAuthorship W3204245666A5011090841 @default.
• W3204245666 hasAuthorship W3204245666A5018814025 @default.
• W3204245666 hasAuthorship W3204245666A5027824032 @default.
• W3204245666 hasAuthorship W3204245666A5031811618 @default.
• W3204245666 hasAuthorship W3204245666A5040205022 @default.
• W3204245666 hasAuthorship W3204245666A5052488776 @default.
• W3204245666 hasAuthorship W3204245666A5064754125 @default.
• W3204245666 hasBestOaLocation W32042456661 @default.
• W3204245666 hasConcept C121608353 @default.
• W3204245666 hasConcept C126322002 @default.
• W3204245666 hasConcept C143998085 @default.
• W3204245666 hasConcept C2776264508 @default.
• W3204245666 hasConcept C2776694085 @default.
• W3204245666 hasConcept C2777701055 @default.
• W3204245666 hasConcept C2778019345 @default.
• W3204245666 hasConcept C2778695046 @default.
• W3204245666 hasConcept C2778820342 @default.
• W3204245666 hasConcept C71924100 @default.
• W3204245666 hasConcept C90924648 @default.
• W3204245666 hasConceptScore W3204245666C121608353 @default.

• next